CME Regulatory Reporting Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Buyout/​LBO
  • Investors
  • 1

CME Regulatory Reporting General Information

Description

Provider of regulatory reporting services intended to simplify complexity of regulatory environments and optimize resources. The company's services offer global transaction reporting services across multiple regulatory regimes, enabling clients to lower costs, eliminate operational risk and provide reporting effectiveness.

Contact Information

Formerly Known As
Abide Financial
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Consulting Services (B2B)
Other Industries
Media and Information Services (B2B)
Accounting, Audit and Tax Services (B2B)
Primary Office
  • 2 Broadgate
  • London EC2M 7UR
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CME Regulatory Reporting Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Buyout/LBO 13-Oct-2016 00.000 Completed Generating Revenue
1. Early Stage VC 07-Sep-2015 00.000 00.000 0000 Completed Startup
To view CME Regulatory Reporting’s complete valuation and funding history, request access »

CME Regulatory Reporting Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary E 000,000 00.000000 000.00 000.00 00 000.00 00.000
To view CME Regulatory Reporting’s complete cap table history, request access »

CME Regulatory Reporting Executive Team (6)

Name Title Board Seat Contact Info
Rasa Balsyte Director, Relationship Management and Business Development
You’re viewing 1 of 6 executive team members. Get the full list »

CME Regulatory Reporting Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
NEX Opportunities Corporate Venture Capital Majority 000 0000 000000 0
To view CME Regulatory Reporting’s complete investors history, request access »